Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with H
| Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
|---|---|---|---|---|---|---|---|
| HAMAMELIS VIRGINIANA TOP WATER | TOPICAL | CREAM | NT00Y05A2V | 50.98%w/w | |||
| HARD FAT | ORAL | CAPSULE, LIQUID FILLED | 8334LX7S21 | 153mg | |||
| HARD FAT | RECTAL | SUPPOSITORY | 8334LX7S21 | 7657mg | |||
| HEXYLENE GLYCOL | TOPICAL | CREAM | 107415 | KEH0A3F75J | 12%w/w | ||
| HEXYLENE GLYCOL | TOPICAL | GEL | 107415 | KEH0A3F75J | 280mg | ||
| HEXYLENE GLYCOL | TOPICAL | OINTMENT | 107415 | KEH0A3F75J | 12%w/w | ||
| HEXYLENE GLYCOL | TOPICAL | SOLUTION | 107415 | KEH0A3F75J | 0.3%w/w | ||
| HIGH DENSITY POLYETHYLENE | DENTAL | PASTE | 9002884 | UG00KM4WR7 | 4%w/w | ||
| HIGH DENSITY POLYETHYLENE | OPHTHALMIC | OINTMENT | 9002884 | UG00KM4WR7 | NA | ||
| HIGH DENSITY POLYETHYLENE | ORAL | CAPSULE | 9002884 | UG00KM4WR7 | 10mg | ||
| HIGH DENSITY POLYETHYLENE | ORAL | CAPSULE, EXTENDED RELEASE | 9002884 | UG00KM4WR7 | 4.53mg | ||
| HIGH DENSITY POLYETHYLENE | ORAL | TABLET | 9002884 | UG00KM4WR7 | 50mg | ||
| HIGH DENSITY POLYETHYLENE | ORAL | TABLET, COATED | 9002884 | UG00KM4WR7 | 25mg | ||
| HIGH DENSITY POLYETHYLENE | ORAL | TABLET, DELAYED RELEASE | 9002884 | UG00KM4WR7 | NA | ||
| HIGH DENSITY POLYETHYLENE | ORAL | TABLET, EXTENDED RELEASE | 9002884 | UG00KM4WR7 | 0.64mg | ||
| HIGH DENSITY POLYETHYLENE | RECTAL | SUPPOSITORY | 9002884 | UG00KM4WR7 | NA | ||
| HIGH DENSITY POLYETHYLENE | TOPICAL | CREAM | 9002884 | UG00KM4WR7 | 54.5%w/w | ||
| HIGH DENSITY POLYETHYLENE | TOPICAL | GEL | 9002884 | UG00KM4WR7 | 26%w/w | ||
| HIGH DENSITY POLYETHYLENE | TOPICAL | LOTION | 9002884 | UG00KM4WR7 | 1.5%w/w | ||
| HIGH DENSITY POLYETHYLENE | TOPICAL | OINTMENT | 9002884 | UG00KM4WR7 | 94%w/w | ||
| HIGH DENSITY POLYETHYLENE | TOPICAL | PASTE | 9002884 | UG00KM4WR7 | 2.5%w/w | ||
| HIGH DENSITY POLYETHYLENE | TOPICAL | TAPE | 9002884 | UG00KM4WR7 | NA | ||
| HIGH DENSITY POLYETHYLENE | TRANSDERMAL | FILM, EXTENDED RELEASE | 9002884 | UG00KM4WR7 | 85mg | ||
| HIGH DENSITY POLYETHYLENE | TRANSDERMAL | SYSTEM | 9002884 | UG00KM4WR7 | NA | ||
| HIGH DENSITY POLYETHYLENE | VAGINAL | JELLY | 9002884 | UG00KM4WR7 | 42.6%w/w | ||
| HIGH DENSITY POLYETHYLENE | VAGINAL | SUPPOSITORY | 9002884 | UG00KM4WR7 | NA | ||
| HIGH FRUCTOSE CORN SYRUP | ORAL | LIQUID | XY6UN3QB6S | 1700mg | |||
| HIGH FRUCTOSE CORN SYRUP | ORAL | SOLUTION | XY6UN3QB6S | 10000mg | |||
| HIGH FRUCTOSE CORN SYRUP | ORAL | SUSPENSION | XY6UN3QB6S | 16200mg | |||
| HIGH FRUCTOSE CORN SYRUP | ORAL | SUSPENSION, EXTENDED RELEASE | XY6UN3QB6S | 2000mg | |||
| HISTIDINE | INTRAVENOUS | INJECTABLE, LIPOSOMAL | 71001 | 4QD397987E | 63mg | ||
| HISTIDINE | INTRAVENOUS | INJECTION | 71001 | 4QD397987E | 4.29mg | ||
| HISTIDINE | INTRAVENOUS | INJECTION, SOLUTION | 71001 | 4QD397987E | 0.09%w/v | ||
| HISTIDINE | INTRAVENOUS | INJECTION, SUSPENSION, LIPOSOMAL | 71001 | 4QD397987E | 0.16%w/v | ||
| HISTIDINE | ORAL | CAPSULE | 71001 | 4QD397987E | 0.76mg | ||
| HISTIDINE | ORAL | SUSPENSION | 71001 | 4QD397987E | 5mg/1ml | ||
| HISTIDINE | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 71001 | 4QD397987E | 3.88mg | ||
| HORNSTEDTIA COSTATA SEED | ORAL | ELIXIR | T44ZYB1BAV | 2.5mg/5ml | |||
| HYALURONATE SODIUM | INTRA-ARTICULAR | INJECTION, SUSPENSION | 9067327 | YSE9PPT4TH | 23mg | ||
| HYALURONATE SODIUM | INTRAMUSCULAR | INJECTION, SUSPENSION | 9067327 | YSE9PPT4TH | 23mg | ||
| HYALURONATE SODIUM | INTRAVITREAL | INJECTION, SUSPENSION | 9067327 | YSE9PPT4TH | 23mg | ||
| HYALURONATE SODIUM | TOPICAL | GEL | 9067327 | YSE9PPT4TH | 463mg | ||
| HYALURONATE SODIUM | TOPICAL | LOTION | 9067327 | YSE9PPT4TH | 0.01%w/w | ||
| HYDROCARBON GEL, PLASTICIZED | DENTAL | PASTE | 8049658 | NA | 50.6%w/w | ||
| HYDROCARBON GEL, PLASTICIZED | OPHTHALMIC | OINTMENT | 8049658 | NA | NA | ||
| HYDROCARBON GEL, PLASTICIZED | TOPICAL | OINTMENT | 8049658 | NA | 97.7%w/w | ||
| HYDROCHLORIC ACID | AURICULAR (OTIC) | SOLUTION | 7647010 | QTT17582CB | 0.37%w/v | ||
| HYDROCHLORIC ACID | AURICULAR (OTIC) | SUSPENSION | 7647010 | QTT17582CB | 0.04%w/v | ||
| HYDROCHLORIC ACID | DENTAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | DENTAL | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | ENDOTRACHEAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | ENDOTRACHEAL | POWDER, FOR SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | EPIDURAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | EPIDURAL | INJECTION, SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | EPIDURAL | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | EXTRACORPOREAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | EXTRACORPOREAL | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INFILTRATION | INJECTION | 7647010 | QTT17582CB | 0.37%w/v | ||
| HYDROCHLORIC ACID | INFILTRATION | INJECTION, SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTERSTITIAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRA-AMNIOTIC | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRA-ARTERIAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRA-ARTERIAL | INJECTION, POWDER, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRA-ARTERIAL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRA-ARTERIAL | INJECTION, SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRA-ARTERIAL | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRA-ARTICULAR | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRA-ARTICULAR | INJECTION, SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRABURSAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRACARDIAC | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRACARDIAC | INJECTION, SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRACAUDAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRACAUDAL | INJECTION, SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRACAVITARY | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRACAVITARY | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRADERMAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRADERMAL | INJECTION, POWDER, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRALESIONAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRALESIONAL | INJECTION, SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAMUSCULAR | INJECTION | 7647010 | QTT17582CB | 306mg | ||
| HYDROCHLORIC ACID | INTRAMUSCULAR | INJECTION, EMULSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAMUSCULAR | INJECTION, SOLUTION | 7647010 | QTT17582CB | 1.1%w/v | ||
| HYDROCHLORIC ACID | INTRAMUSCULAR | INJECTION, SOLUTION, CONCENTRATE | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAMUSCULAR | INJECTION, SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAMUSCULAR | LIQUID | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAMUSCULAR | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAMUSCULAR | SUSPENSION, EXTENDED RELEASE | 7647010 | QTT17582CB | 5mg | ||
| HYDROCHLORIC ACID | INTRAOCULAR | INJECTION, SOLUTION, CONCENTRATE | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAOCULAR | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAPERITONEAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAPERITONEAL | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAPLEURAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRASPINAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRASYNOVIAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRASYNOVIAL | INJECTION, SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRATHECAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRATHECAL | INJECTION, POWDER, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRATHECAL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRATHECAL | INJECTION, SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRATHECAL | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRATUMOR | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRATUMOR | INJECTION, POWDER, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRATYMPANIC | SUSPENSION | 7647010 | QTT17582CB | 0.14%w/w | ||
| HYDROCHLORIC ACID | INTRAVASCULAR | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVASCULAR | INJECTION, SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVASCULAR | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVENOUS | INJECTABLE, LIPOSOMAL | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVENOUS | INJECTION | 7647010 | QTT17582CB | 720mg | ||
| HYDROCHLORIC ACID | INTRAVENOUS | INJECTION, EMULSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 7647010 | QTT17582CB | 0.18%w/v | ||
| HYDROCHLORIC ACID | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 7647010 | QTT17582CB | 4.17mg | ||
| HYDROCHLORIC ACID | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7647010 | QTT17582CB | 160mg | ||
| HYDROCHLORIC ACID | INTRAVENOUS | INJECTION, SOLUTION | 7647010 | QTT17582CB | 0.7%w/v | ||
| HYDROCHLORIC ACID | INTRAVENOUS | INJECTION, SOLUTION, CONCENTRATE | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVENOUS | INJECTION, SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVENOUS | INJECTION, SUSPENSION, LIPOSOMAL | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVENOUS | LIQUID | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVENOUS | POWDER | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVENOUS | POWDER, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVENOUS | SOLUTION | 7647010 | QTT17582CB | 18.25mg | ||
| HYDROCHLORIC ACID | INTRAVENOUS | SOLUTION, CONCENTRATE | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVESICAL | INJECTION, SOLUTION | 7647010 | QTT17582CB | 157mg | ||
| HYDROCHLORIC ACID | INTRAVITREAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | INTRAVITREAL | INJECTION, SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | IONTOPHORESIS | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | IRRIGATION | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | NASAL | DROPS | 7647010 | QTT17582CB | 10ml | ||
| HYDROCHLORIC ACID | NASAL | LIQUID | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | NASAL | SOLUTION | 7647010 | QTT17582CB | 247mg/100ml | ||
| HYDROCHLORIC ACID | NASAL | SPRAY | 7647010 | QTT17582CB | 10ml | ||
| HYDROCHLORIC ACID | NASAL | SPRAY, METERED | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | NASAL | SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | OPHTHALMIC | EMULSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | OPHTHALMIC | GEL | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | OPHTHALMIC | SOLUTION | 7647010 | QTT17582CB | 0.31%w/v | ||
| HYDROCHLORIC ACID | OPHTHALMIC | SOLUTION/ DROPS | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | OPHTHALMIC | SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | OPHTHALMIC | SUSPENSION/ DROPS | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | ORAL | CAPSULE | 7647010 | QTT17582CB | 7mg | ||
| HYDROCHLORIC ACID | ORAL | CAPSULE, LIQUID FILLED | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | ORAL | CONCENTRATE | 7647010 | QTT17582CB | 2.17mg/1ml | ||
| HYDROCHLORIC ACID | ORAL | LIQUID | 7647010 | QTT17582CB | 4.46mg/1ml | ||
| HYDROCHLORIC ACID | ORAL | POWDER, FOR SUSPENSION | 7647010 | QTT17582CB | 125mg | ||
| HYDROCHLORIC ACID | ORAL | SOLUTION | 7647010 | QTT17582CB | 223mg | ||
| HYDROCHLORIC ACID | ORAL | SUSPENSION | 7647010 | QTT17582CB | 100mg | ||
| HYDROCHLORIC ACID | ORAL | SUSPENSION, EXTENDED RELEASE | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | ORAL | SYRUP | 7647010 | QTT17582CB | 2.03mg/1ml | ||
| HYDROCHLORIC ACID | ORAL | TABLET | 7647010 | QTT17582CB | 2.32mg | ||
| HYDROCHLORIC ACID | ORAL | TABLET, EXTENDED RELEASE | 7647010 | QTT17582CB | 24mg | ||
| HYDROCHLORIC ACID | ORAL | TABLET, FILM COATED | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | PARENTERAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | PARENTERAL | INJECTION, POWDER, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | PARENTERAL | INJECTION, SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | PERIDURAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | PERINEURAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | RECTAL | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | RESPIRATORY (INHALATION) | AEROSOL, METERED | 7647010 | QTT17582CB | 0.7%w/w | ||
| HYDROCHLORIC ACID | RESPIRATORY (INHALATION) | AEROSOL, SPRAY | 7647010 | QTT17582CB | 1.5%w/w | ||
| HYDROCHLORIC ACID | RESPIRATORY (INHALATION) | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | RESPIRATORY (INHALATION) | SPRAY | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | RETROBULBAR | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SOFT TISSUE | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SOFT TISSUE | INJECTION, SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBARACHNOID | INJECTION, SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBCONJUNCTIVAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBCUTANEOUS | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBCUTANEOUS | INJECTION, EMULSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBCUTANEOUS | INJECTION, SOLUTION | 7647010 | QTT17582CB | 0.61%w/v | ||
| HYDROCHLORIC ACID | SUBCUTANEOUS | INJECTION, SOLUTION, CONCENTRATE | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBCUTANEOUS | INJECTION, SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBCUTANEOUS | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBCUTANEOUS | SUSPENSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBCUTANEOUS | SUSPENSION, EXTENDED RELEASE | 7647010 | QTT17582CB | 5mg | ||
| HYDROCHLORIC ACID | SUBMUCOSAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | SUBMUCOSAL | INJECTION, SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | TOPICAL | AEROSOL, FOAM | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | TOPICAL | CREAM | 7647010 | QTT17582CB | 2.1%w/w | ||
| HYDROCHLORIC ACID | TOPICAL | EMULSION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | TOPICAL | GEL | 7647010 | QTT17582CB | 0.5%w/w | ||
| HYDROCHLORIC ACID | TOPICAL | JELLY | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | TOPICAL | LOTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | TOPICAL | OINTMENT | 7647010 | QTT17582CB | NA | ||
| HYDROCHLORIC ACID | TOPICAL | SHAMPOO | 7647010 | QTT17582CB | 4%w/w | ||
| HYDROCHLORIC ACID | TOPICAL | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | TOPICAL | SOLUTION/ DROPS | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | TOPICAL | SPONGE | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | TOPICAL | SUSPENSION/ DROPS | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | TRANSDERMAL | GEL | 7647010 | QTT17582CB | 0.02%w/w | ||
| HYDROCHLORIC ACID | URETERAL | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | URETHRAL | INJECTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROCHLORIC ACID | URETHRAL | SOLUTION | 7647010 | QTT17582CB | ADJ PH | ||
| HYDROGEN PEROXIDE | ORAL | TABLET, DELAYED RELEASE | 7722841 | BBX060AN9V | NA | ||
| HYDROGEN PEROXIDE | TOPICAL | SOLUTION | 7722841 | BBX060AN9V | 0.16%w/w | ||
| HYDROGEN PEROXIDE | TOPICAL | SPONGE | 7722841 | BBX060AN9V | 0.2%w/w | ||
| HYDROGENATED CASTOR OIL | ORAL | CAPSULE | 8001783 | ZF94AP8MEY | 405mg | ||
| HYDROGENATED CASTOR OIL | ORAL | CAPSULE, DELAYED RELEASE | 8001783 | ZF94AP8MEY | 3.1mg | ||
| HYDROGENATED CASTOR OIL | ORAL | CAPSULE, EXTENDED RELEASE | 8001783 | ZF94AP8MEY | 410.82mg | ||
| HYDROGENATED CASTOR OIL | ORAL | TABLET | 8001783 | ZF94AP8MEY | 232mg | ||
| HYDROGENATED CASTOR OIL | ORAL | TABLET, DELAYED RELEASE | 8001783 | ZF94AP8MEY | 1337mg | ||
| HYDROGENATED CASTOR OIL | ORAL | TABLET, EXTENDED RELEASE | 8001783 | ZF94AP8MEY | 393mg | ||
| HYDROGENATED CASTOR OIL | ORAL | TABLET, FILM COATED | 8001783 | ZF94AP8MEY | 17mg | ||
| HYDROGENATED CASTOR OIL | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 8001783 | ZF94AP8MEY | 5mg | ||
| HYDROGENATED CASTOR OIL | ORAL | TABLET, FOR SUSPENSION | 8001783 | ZF94AP8MEY | 17mg | ||
| HYDROGENATED CASTOR OIL | SUBLINGUAL | TABLET | 8001783 | ZF94AP8MEY | 1.6mg | ||
| HYDROGENATED CASTOR OIL | TOPICAL | AEROSOL, FOAM | 8001783 | ZF94AP8MEY | 2%w/w | ||
| HYDROGENATED CASTOR OIL | TOPICAL | LIQUID | 8001783 | ZF94AP8MEY | 0.24%w/w | ||
| HYDROGENATED CASTOR OIL | TOPICAL | SUSPENSION | 8001783 | ZF94AP8MEY | 286mg | ||
| HYDROGENATED COCONUT OIL | RECTAL | SUPPOSITORY | 84836986 | JY81OXM1OM | NA | ||
| HYDROGENATED COTTONSEED OIL | ORAL | CAPSULE | 68334009 | Z82Y2C65EA | 21.78mg | ||
| HYDROGENATED COTTONSEED OIL | ORAL | CAPSULE, EXTENDED RELEASE | 68334009 | Z82Y2C65EA | 58mg | ||
| HYDROGENATED COTTONSEED OIL | ORAL | TABLET | 68334009 | Z82Y2C65EA | 72mg | ||
| HYDROGENATED COTTONSEED OIL | ORAL | TABLET, CHEWABLE | 68334009 | Z82Y2C65EA | NA | ||
| HYDROGENATED COTTONSEED OIL | ORAL | TABLET, COATED | 68334009 | Z82Y2C65EA | 0.6mg | ||
| HYDROGENATED COTTONSEED OIL | ORAL | TABLET, DELAYED RELEASE | 68334009 | Z82Y2C65EA | 4mg | ||
| HYDROGENATED COTTONSEED OIL | ORAL | TABLET, EXTENDED RELEASE | 68334009 | Z82Y2C65EA | 2280mg | ||
| HYDROGENATED COTTONSEED OIL | SUBLINGUAL | TABLET | 68334009 | Z82Y2C65EA | 2mg | ||
| HYDROGENATED PALM OIL | RECTAL | SUPPOSITORY | 68514749 | 257THB963H | NA | ||
| HYDROGENATED SOYBEAN LECITHIN | AURICULAR (OTIC) | SUSPENSION | 308068113 | H1109Z9J4N | 0.15%w/v | ||
| HYDROGENATED SOYBEAN LECITHIN | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 308068113 | H1109Z9J4N | 213mg | ||
| HYDROGENATED SOYBEAN LECITHIN | ORAL | TABLET | 308068113 | H1109Z9J4N | 0.21mg | ||
| HYDROGENATED SOYBEAN LECITHIN | TOPICAL | CREAM | 308068113 | H1109Z9J4N | 1.5%w/w | ||
| HYDROGENATED SOYBEAN OIL | ORAL | CAPSULE | 8016704 | A2M91M918C | 95mg | ||
| HYDROGENATED SOYBEAN OIL | ORAL | TABLET | 8016704 | A2M91M918C | 13.5mg | ||
| HYDROGENATED SOYBEAN OIL | ORAL | TABLET, COATED | 8016704 | A2M91M918C | 3mg | ||
| HYDROGENATED SOYBEAN OIL | ORAL | TABLET, EXTENDED RELEASE | 8016704 | A2M91M918C | 96mg | ||
| HYDROGENATED SOYBEAN PHOSPHATIDYLCHOLINE | INTRAVENOUS | INJECTABLE, LIPOSOMAL | 97281486 | QHQ97HF0PY | 388mg | ||
| HYDROGENATED SOYBEAN PHOSPHATIDYLCHOLINE | INTRAVENOUS | INJECTION, SUSPENSION, LIPOSOMAL | 97281486 | QHQ97HF0PY | 0.96%w/v | ||
| HYDROGENATED STARCH HYDROLYSATE | ORAL | SOLUTION | 68425172 | 27F77DSJ5V | 300mg/1ml | ||
| HYDROGENATED STARCH HYDROLYSATE | SUBLINGUAL | FILM | 68425172 | 27F77DSJ5V | 18mg | ||
| HYDROXYETHYL CELLULOSE | AURICULAR (OTIC) | SOLUTION | 9004620 | T4V6TWG28D | 0.25%w/w | ||
| HYDROXYETHYL CELLULOSE | OPHTHALMIC | SOLUTION | 9004620 | T4V6TWG28D | 1mg | ||
| HYDROXYETHYL CELLULOSE | OPHTHALMIC | SUSPENSION | 9004620 | T4V6TWG28D | 0.05%w/w | ||
| HYDROXYETHYL CELLULOSE | OPHTHALMIC | SUSPENSION/ DROPS | 9004620 | T4V6TWG28D | 0.35%w/w | ||
| HYDROXYETHYL CELLULOSE | ORAL | SUSPENSION | 9004620 | T4V6TWG28D | 10mg | ||
| HYDROXYETHYL CELLULOSE | ORAL | SYRUP | 9004620 | T4V6TWG28D | 7.5mg/5ml | ||
| HYDROXYETHYL CELLULOSE | ORAL | TABLET | 9004620 | T4V6TWG28D | NA | ||
| HYDROXYETHYL CELLULOSE | ORAL | TABLET, CHEWABLE | 9004620 | T4V6TWG28D | 11.8mg | ||
| HYDROXYETHYL CELLULOSE | ORAL | TABLET, COATED | 9004620 | T4V6TWG28D | NA | ||
| HYDROXYETHYL CELLULOSE | ORAL | TABLET, EXTENDED RELEASE | 9004620 | T4V6TWG28D | 20mg | ||
| HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%) | TOPICAL | SOLUTION | R33S7TK2EP | 0.6%w/v | |||
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | BUCCAL | FILM | 9004620 | 8136Y38GY5 | 55mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | BUCCAL | FILM, SOLUBLE | 9004620 | 8136Y38GY5 | 161mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | ORAL | CAPSULE | 9004620 | 8136Y38GY5 | 20mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | ORAL | SOLUTION | 9004620 | 8136Y38GY5 | 1867mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | ORAL | SUSPENSION | 9004620 | 8136Y38GY5 | 1200mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | ORAL | SYRUP | 9004620 | 8136Y38GY5 | 100mg/5ml | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | ORAL | TABLET | 9004620 | 8136Y38GY5 | 16mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | ORAL | TABLET, EXTENDED RELEASE | 9004620 | 8136Y38GY5 | 150mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | ORAL | TABLET, FILM COATED | 9004620 | 8136Y38GY5 | 1mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004620 | 8136Y38GY5 | 10.7mg | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | AURICULAR (OTIC) | SUSPENSION | 9004620 | S38J6RZN16 | 0.2%w/w | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | NASAL | SPRAY | 9004620 | S38J6RZN16 | 0.1mg/0.2ml | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | OPHTHALMIC | SOLUTION | 9004620 | S38J6RZN16 | 0.5%w/v | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | OPHTHALMIC | SOLUTION/ DROPS | 9004620 | S38J6RZN16 | 0.5%w/v | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | OPHTHALMIC | SUSPENSION | 9004620 | S38J6RZN16 | 0.25%w/v | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | ORAL | POWDER, FOR SUSPENSION | 9004620 | S38J6RZN16 | 560mg | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | ORAL | SOLUTION | 9004620 | S38J6RZN16 | 3mg | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | ORAL | SUSPENSION | 9004620 | S38J6RZN16 | 100mg | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | ORAL | SYRUP | 9004620 | S38J6RZN16 | 2mg/5ml | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | ORAL | TABLET | 9004620 | S38J6RZN16 | 22.96mg | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | ORAL | TABLET, CHEWABLE | 9004620 | S38J6RZN16 | 5.9mg | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | ORAL | TABLET, EXTENDED RELEASE | 9004620 | S38J6RZN16 | 350mg | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004620 | S38J6RZN16 | 85.5mg | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | TOPICAL | GEL | 9004620 | S38J6RZN16 | 1.75%w/w | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | TOPICAL | LOTION | 9004620 | S38J6RZN16 | 0.2%w/v | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | TOPICAL | SOLUTION | 9004620 | S38J6RZN16 | 0.21%w/v | ||
| HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%) | TOPICAL | SUSPENSION | 9004620 | S38J6RZN16 | 0.69%w/w | ||
| HYDROXYETHYL CELLULOSE (280 MPA.S AT 2%) | ORAL | SOLUTION | 9004620 | 12VCE9HR9E | 200mg | ||
| HYDROXYETHYL CELLULOSE (280 MPA.S AT 2%) | ORAL | TABLET, EXTENDED RELEASE | 9004620 | 12VCE9HR9E | 40mg | ||
| HYDROXYETHYL CELLULOSE (280 MPA.S AT 2%) | TOPICAL | SPRAY | 9004620 | 12VCE9HR9E | 0.05%w/w | ||
| HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) | OPHTHALMIC | SOLUTION | 9004620 | ZYD53NBL45 | 1.6%w/v | ||
| HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) | OPHTHALMIC | SOLUTION/ DROPS | 9004620 | ZYD53NBL45 | 0.48%w/v | ||
| HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) | ORAL | CAPSULE | 9004620 | ZYD53NBL45 | 2.98mg | ||
| HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) | ORAL | SOLUTION | 9004620 | ZYD53NBL45 | 3.5mg/1ml | ||
| HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) | ORAL | TABLET, EXTENDED RELEASE | 9004620 | ZYD53NBL45 | 800mg | ||
| HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004620 | ZYD53NBL45 | 140mg | ||
| HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) | TOPICAL | GEL | 9004620 | ZYD53NBL45 | 25mg | ||
| HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) | TOPICAL | SOLUTION | 9004620 | ZYD53NBL45 | 0.26%w/v | ||
| HYDROXYETHYL CELLULOSE (5000 MPA.S AT 1%) | OPHTHALMIC | SOLUTION | 9004620 | X70SE62ZAR | 0.52%w/v | ||
| HYDROXYETHYL CELLULOSE (5000 MPA.S AT 1%) | TOPICAL | SOLUTION | 9004620 | X70SE62ZAR | 0.52%w/v | ||
| HYDROXYETHYL CELLULOSE (6500 MPA.S AT 2%) | ORAL | SOLUTION | 9004620 | 2Q40985DRM | 22.5mg/5ml | ||
| HYDROXYETHYL CELLULOSE (6500 MPA.S AT 2%) | ORAL | SYRUP | 9004620 | 2Q40985DRM | 8mg/5ml | ||
| HYDROXYETHYL CELLULOSE (6500 MPA.S AT 2%) | ORAL | TABLET, EXTENDED RELEASE | 9004620 | 2Q40985DRM | 300mg | ||
| HYDROXYETHYL ETHYLCELLULOSE | OPHTHALMIC | SOLUTION/ DROPS | 9004584 | ZDN57Z154K | 0.48%w/v | ||
| HYDROXYETHYL ETHYLCELLULOSE | ORAL | TABLET, EXTENDED RELEASE | 9004584 | ZDN57Z154K | 40.63mg | ||
| HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID | INTRAVENOUS | INJECTION | 7365459 | RWW266YE9I | 41mg | ||
| HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID | INTRAVENOUS | LIQUID | 7365459 | RWW266YE9I | 0.6%w/v | ||
| HYDROXYMETHYL CELLULOSE | ORAL | CAPSULE, EXTENDED RELEASE | 37353596 | 273FM27VK1 | 1.6mg | ||
| HYDROXYMETHYL CELLULOSE | ORAL | TABLET | 37353596 | 273FM27VK1 | 4mg | ||
| HYDROXYMETHYL CELLULOSE | ORAL | TABLET, FILM COATED | 37353596 | 273FM27VK1 | 30mg | ||
| HYDROXYPROPYL .GAMMA.-CYCLODEXTRIN | OPHTHALMIC | SOLUTION | 128446344 | P6BYU725IU | 17mg | ||
| HYDROXYPROPYL .GAMMA.-CYCLODEXTRIN | TOPICAL | SOLUTION | 128446344 | P6BYU725IU | 1.5%w/v | ||
| HYDROXYPROPYL BETADEX | INTRAMUSCULAR | INJECTION | 128446355 | 1I96OHX6EK | 1333mg | ||
| HYDROXYPROPYL BETADEX | INTRAVENOUS | INJECTION | 128446355 | 1I96OHX6EK | 1333mg | ||
| HYDROXYPROPYL BETADEX | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 128446355 | 1I96OHX6EK | 20%w/v | ||
| HYDROXYPROPYL BETADEX | ORAL | CAPSULE | 128446355 | 1I96OHX6EK | 0.6mg | ||
| HYDROXYPROPYL BETADEX | ORAL | SOLUTION | 128446355 | 1I96OHX6EK | 8000mg | ||
| HYDROXYPROPYL BETADEX | ORAL | TABLET | 128446355 | 1I96OHX6EK | 600mg | ||
| HYDROXYPROPYL BETADEX | ORAL | TABLET, ORALLY DISINTEGRATING | 128446355 | 1I96OHX6EK | 22mg | ||
| HYDROXYPROPYL CELLULOSE | ORAL | GRANULE, FOR SUSPENSION | 9004642 | 9XZ8H6N6OH | 251mg | ||
| HYDROXYPROPYL CELLULOSE | ORAL | TABLET | 9004642 | 9XZ8H6N6OH | 128mg | ||
| HYDROXYPROPYL CELLULOSE | ORAL | TABLET, DELAYED RELEASE | 9004642 | 9XZ8H6N6OH | 4mg | ||
| HYDROXYPROPYL CELLULOSE | ORAL | TABLET, EXTENDED RELEASE | 9004642 | 9XZ8H6N6OH | 413mg | ||
| HYDROXYPROPYL CELLULOSE | ORAL | TABLET, FILM COATED | 9004642 | 9XZ8H6N6OH | 25mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | ORAL | CAPSULE | 9004642 | 5Y0974F5PW | 139mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | ORAL | CAPSULE, DELAYED RELEASE | 9004642 | 5Y0974F5PW | 90mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | ORAL | CAPSULE, EXTENDED RELEASE | 9004642 | 5Y0974F5PW | 375mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | ORAL | GRANULE | 9004642 | 5Y0974F5PW | 8mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | ORAL | SUSPENSION | 9004642 | 5Y0974F5PW | 1249mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | ORAL | TABLET | 9004642 | 5Y0974F5PW | 613mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | ORAL | TABLET, CHEWABLE | 9004642 | 5Y0974F5PW | 1050mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | ORAL | TABLET, DELAYED RELEASE | 9004642 | 5Y0974F5PW | 528mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | ORAL | TABLET, EXTENDED RELEASE | 9004642 | 5Y0974F5PW | 356mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | ORAL | TABLET, FILM COATED | 9004642 | 5Y0974F5PW | 92mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 9004642 | 5Y0974F5PW | 90mg | ||
| HYDROXYPROPYL CELLULOSE (110000 WAMW) | TRANSDERMAL | FILM, EXTENDED RELEASE | 9004642 | 5Y0974F5PW | 6mg | ||
| HYDROXYPROPYL CELLULOSE (160000 WAMW) | ORAL | TABLET | 9004642 | 0A7M0N7SPE | 8mg | ||
| HYDROXYPROPYL CELLULOSE (160000 WAMW) | ORAL | TABLET, EXTENDED RELEASE | 9004642 | 0A7M0N7SPE | 180mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | BUCCAL | FILM | 9004642 | RFW2ET671P | 87mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | CAPSULE | 9004642 | RFW2ET671P | 120mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | CAPSULE, COATED PELLETS | 9004642 | RFW2ET671P | 41.4mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | CAPSULE, DELAYED RELEASE | 9004642 | RFW2ET671P | 150mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | CAPSULE, EXTENDED RELEASE | 9004642 | RFW2ET671P | 214mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | GRANULE | 9004642 | RFW2ET671P | 13mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | GRANULE, FOR SUSPENSION | 9004642 | RFW2ET671P | 194mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | LOZENGE | 9004642 | RFW2ET671P | 500mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | POWDER | 9004642 | RFW2ET671P | 244mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | POWDER, FOR SUSPENSION | 9004642 | RFW2ET671P | 200mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | SUSPENSION | 9004642 | RFW2ET671P | 40mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | TABLET | 9004642 | RFW2ET671P | 230mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | TABLET, CHEWABLE | 9004642 | RFW2ET671P | 10mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | TABLET, COATED | 9004642 | RFW2ET671P | 13.6mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | TABLET, DELAYED RELEASE | 9004642 | RFW2ET671P | 450mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | TABLET, EXTENDED RELEASE | 9004642 | RFW2ET671P | 864mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | TABLET, FILM COATED | 9004642 | RFW2ET671P | 131.67mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004642 | RFW2ET671P | 187.6mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | TABLET, ORALLY DISINTEGRATING | 9004642 | RFW2ET671P | 4mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 9004642 | RFW2ET671P | 39.2mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | SUBLINGUAL | TABLET | 9004642 | RFW2ET671P | 1mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | TOPICAL | GEL | 9004642 | RFW2ET671P | 222mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | TOPICAL | LOTION | 9004642 | RFW2ET671P | 6mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | TOPICAL | LOTION, AUGMENTED | 9004642 | RFW2ET671P | 0.2%w/w | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | TOPICAL | SOLUTION | 9004642 | RFW2ET671P | 0.1%w/v | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | TRANSDERMAL | FILM, EXTENDED RELEASE | 9004642 | RFW2ET671P | 19mg | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW) | TRANSDERMAL | GEL | 9004642 | RFW2ET671P | 20mg | ||
| HYDROXYPROPYL CELLULOSE (20000 WAMW) | ORAL | CAPSULE, DELAYED RELEASE | 9004642 | KZQ570MOA5 | 51mg | ||
| HYDROXYPROPYL CELLULOSE (20000 WAMW) | ORAL | TABLET | 9004642 | KZQ570MOA5 | 50mg | ||
| HYDROXYPROPYL CELLULOSE (20000 WAMW) | ORAL | TABLET, DELAYED RELEASE | 9004642 | KZQ570MOA5 | 212mg | ||
| HYDROXYPROPYL CELLULOSE (20000 WAMW) | ORAL | TABLET, EXTENDED RELEASE | 9004642 | KZQ570MOA5 | 25mg | ||
| HYDROXYPROPYL CELLULOSE (20000 WAMW) | ORAL | TABLET, FILM COATED | 9004642 | KZQ570MOA5 | 30mg | ||
| HYDROXYPROPYL CELLULOSE (20000 WAMW) | ORAL | TABLET, ORALLY DISINTEGRATING | 9004642 | KZQ570MOA5 | 3mg | ||
| HYDROXYPROPYL CELLULOSE (430000 WAMW) | ORAL | TABLET | 9004642 | VQ8ZWO78F6 | 18mg | ||
| HYDROXYPROPYL CELLULOSE (430000 WAMW) | ORAL | TABLET, EXTENDED RELEASE | 9004642 | VQ8ZWO78F6 | 170mg | ||
| HYDROXYPROPYL CELLULOSE (430000 WAMW) | TOPICAL | LOTION, AUGMENTED | 9004642 | VQ8ZWO78F6 | 37mg | ||
| HYDROXYPROPYL CELLULOSE (430000 WAMW) | TOPICAL | SOLUTION | 9004642 | VQ8ZWO78F6 | 200mg | ||
| HYDROXYPROPYL CELLULOSE (45000 WAMW) | ORAL | TABLET | 9004642 | 8VAB711C5E | 102mg | ||
| HYDROXYPROPYL CELLULOSE (45000 WAMW) | ORAL | TABLET, CHEWABLE | 9004642 | 8VAB711C5E | 57mg | ||
| HYDROXYPROPYL CELLULOSE (45000 WAMW) | ORAL | TABLET, EXTENDED RELEASE | 9004642 | 8VAB711C5E | 140mg | ||
| HYDROXYPROPYL CELLULOSE (650000 WAMW) | ORAL | TABLET, EXTENDED RELEASE | 1L0RPI3ASP | 132mg | |||
| HYDROXYPROPYL CELLULOSE (70000 WAMW) | ORAL | CAPSULE, DELAYED RELEASE | 9004642 | 66O7AQV0RT | 83mg | ||
| HYDROXYPROPYL CELLULOSE (70000 WAMW) | ORAL | CAPSULE, EXTENDED RELEASE | 9004642 | 66O7AQV0RT | 23mg | ||
| HYDROXYPROPYL CELLULOSE (70000 WAMW) | ORAL | TABLET, FILM COATED | 9004642 | 66O7AQV0RT | 15mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | BUCCAL | FILM | 9004642 | UKE75GEA7F | 100mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | BUCCAL | FILM, SOLUBLE | 9004642 | UKE75GEA7F | 292mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | BUCCAL | GUM, CHEWING | 9004642 | UKE75GEA7F | 670mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | CAPSULE | 9004642 | UKE75GEA7F | 69mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | CAPSULE, DELAYED RELEASE | 9004642 | UKE75GEA7F | 114mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | CAPSULE, EXTENDED RELEASE | 9004642 | UKE75GEA7F | 60mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | GRANULE | 9004642 | UKE75GEA7F | 3mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | LOZENGE | 9004642 | UKE75GEA7F | 500mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | POWDER, FOR SUSPENSION | 9004642 | UKE75GEA7F | 54mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | SUSPENSION | 9004642 | UKE75GEA7F | 67mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | TABLET | 9004642 | UKE75GEA7F | 594mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | TABLET, CHEWABLE | 9004642 | UKE75GEA7F | 19mg | Y | |
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | TABLET, COATED | 9004642 | UKE75GEA7F | 88mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | TABLET, DELAYED RELEASE | 9004642 | UKE75GEA7F | 630mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | TABLET, EXTENDED RELEASE | 9004642 | UKE75GEA7F | 364mg | ||
| HYDROXYPROPYL CELLULOSE (90000 WAMW) | ORAL | TABLET, FILM COATED | 9004642 | UKE75GEA7F | 32mg | ||
| HYMETELLOSE (50 MPA.S) | ORAL | TABLET | 9032422 | 0MGW7Q3QG4 | 24mg | ||
| HYPROMELLOSE | NASAL | SPRAY | 9004653 | 3NXW29V3WO | 1mg | ||
| HYPROMELLOSE | OPHTHALMIC | SOLUTION | 9004653 | 3NXW29V3WO | 0.5%w/v | ||
| HYPROMELLOSE | OPHTHALMIC | SOLUTION/ DROPS | 9004653 | 3NXW29V3WO | 0.1%w/v | ||
| HYPROMELLOSE | OPHTHALMIC | SUSPENSION | 9004653 | 3NXW29V3WO | 0.5%w/w | ||
| HYPROMELLOSE | OPHTHALMIC | SUSPENSION/ DROPS | 9004653 | 3NXW29V3WO | 0.12%w/v | ||
| HYPROMELLOSE | ORAL | CAPSULE | 9004653 | 3NXW29V3WO | 1488mg | ||
| HYPROMELLOSE | ORAL | CAPSULE, COATED PELLETS | 9004653 | 3NXW29V3WO | 3.32mg | ||
| HYPROMELLOSE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 9004653 | 3NXW29V3WO | NA | ||
| HYPROMELLOSE | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | 3NXW29V3WO | 105mg | ||
| HYPROMELLOSE | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | 3NXW29V3WO | 204mg | ||
| HYPROMELLOSE | ORAL | GRANULE, DELAYED RELEASE | 9004653 | 3NXW29V3WO | 17.2mg | ||
| HYPROMELLOSE | ORAL | GRANULE, FOR SUSPENSION | 9004653 | 3NXW29V3WO | 1.7mg | ||
| HYPROMELLOSE | ORAL | POWDER, FOR SUSPENSION | 9004653 | 3NXW29V3WO | 65mg/5ml | ||
| HYPROMELLOSE | ORAL | SOLUTION | 9004653 | 3NXW29V3WO | 3.7mg/1ml | ||
| HYPROMELLOSE | ORAL | SUSPENSION | 9004653 | 3NXW29V3WO | 305mg | ||
| HYPROMELLOSE | ORAL | SYRUP | 9004653 | 3NXW29V3WO | 90mg | ||
| HYPROMELLOSE | ORAL | TABLET | 9004653 | 3NXW29V3WO | 1127mg | ||
| HYPROMELLOSE | ORAL | TABLET, CHEWABLE | 9004653 | 3NXW29V3WO | 11.8mg | ||
| HYPROMELLOSE | ORAL | TABLET, COATED | 9004653 | 3NXW29V3WO | 58mg | ||
| HYPROMELLOSE | ORAL | TABLET, DELAYED RELEASE | 9004653 | 3NXW29V3WO | 71mg | ||
| HYPROMELLOSE | ORAL | TABLET, EXTENDED RELEASE | 9004653 | 3NXW29V3WO | 1472mg | ||
| HYPROMELLOSE | ORAL | TABLET, FILM COATED | 9004653 | 3NXW29V3WO | 582mg | ||
| HYPROMELLOSE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | 3NXW29V3WO | 221mg | ||
| HYPROMELLOSE | ORAL | TABLET, ORALLY DISINTEGRATING | 9004653 | 3NXW29V3WO | 41mg | ||
| HYPROMELLOSE | RECTAL | GEL | 9004653 | 3NXW29V3WO | 348mg | ||
| HYPROMELLOSE | TOPICAL | CREAM | 9004653 | 3NXW29V3WO | 0.1%w/w | ||
| HYPROMELLOSE | TOPICAL | JELLY | 9004653 | 3NXW29V3WO | NA | ||
| HYPROMELLOSE | TOPICAL | LOTION | 9004653 | 3NXW29V3WO | 0.1%w/w | ||
| HYPROMELLOSE | TOPICAL | SHAMPOO | 9004653 | 3NXW29V3WO | 3%w/w | ||
| HYPROMELLOSE | TOPICAL | SOLUTION | 9004653 | 3NXW29V3WO | 4%w/v | ||
| HYPROMELLOSE | TOPICAL | SYSTEM | 9004653 | 3NXW29V3WO | 54mg | ||
| HYPROMELLOSE | VAGINAL | INSERT | 9004653 | 3NXW29V3WO | 54.21mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | BUCCAL | TABLET | 9004653 | B1QE5P712K | 21mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | ORAL | CAPSULE | 9004653 | B1QE5P712K | 5mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | B1QE5P712K | 630mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | B1QE5P712K | 79mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | ORAL | POWDER, FOR SUSPENSION | 9004653 | B1QE5P712K | 250mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | ORAL | SUSPENSION | 9004653 | B1QE5P712K | 50mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | ORAL | SYRUP | 9004653 | B1QE5P712K | 100mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | ORAL | TABLET | 9004653 | B1QE5P712K | 942mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004653 | B1QE5P712K | 360mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | B1QE5P712K | 1700mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | B1QE5P712K | 360mg | ||
| HYPROMELLOSE 2208 (100 MPA.S) | TOPICAL | LOTION | 9004653 | B1QE5P712K | 0.1%w/w | ||
| HYPROMELLOSE 2208 (100 MPA.S) | VAGINAL | INSERT | 9004653 | B1QE5P712K | 16mg | ||
| HYPROMELLOSE 2208 (100000 MPA.S) | ORAL | CAPSULE | 9004653 | VM7F0B23ZI | 31mg | ||
| HYPROMELLOSE 2208 (100000 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | VM7F0B23ZI | 900mg | ||
| HYPROMELLOSE 2208 (100000 MPA.S) | ORAL | TABLET | 9004653 | VM7F0B23ZI | 1296mg | ||
| HYPROMELLOSE 2208 (100000 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | VM7F0B23ZI | 2147mg | ||
| HYPROMELLOSE 2208 (100000 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | VM7F0B23ZI | 1320mg | ||
| HYPROMELLOSE 2208 (100000 MPA.S) | TOPICAL | LOTION | 9004653 | VM7F0B23ZI | 7mg | ||
| HYPROMELLOSE 2208 (1500 MPA.S) | ORAL | SUSPENSION | L4RXU2VPD6 | 75mg | |||
| HYPROMELLOSE 2208 (15000 MPA.S) | BUCCAL | TABLET | 9004653 | Z78RG6M2N2 | 17mg | ||
| HYPROMELLOSE 2208 (15000 MPA.S) | ORAL | CAPSULE | 9004653 | Z78RG6M2N2 | 80.25mg | ||
| HYPROMELLOSE 2208 (15000 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | Z78RG6M2N2 | 222mg | ||
| HYPROMELLOSE 2208 (15000 MPA.S) | ORAL | TABLET | 9004653 | Z78RG6M2N2 | 323.28mg | ||
| HYPROMELLOSE 2208 (15000 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | Z78RG6M2N2 | 4050mg | ||
| HYPROMELLOSE 2208 (15000 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | Z78RG6M2N2 | 2640mg | ||
| HYPROMELLOSE 2208 (200000 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | LJY3MA129D | 720mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | CAPSULE | 9004653 | 9H4L916OBU | 19mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | 9H4L916OBU | 40mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | 9H4L916OBU | 24mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | SUSPENSION | 9004653 | 9H4L916OBU | 15mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | TABLET | 9004653 | 9H4L916OBU | 428mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004653 | 9H4L916OBU | 7mg | ||
| HYPROMELLOSE 2208 (3 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | 9H4L916OBU | 470mg | ||
| HYPROMELLOSE 2208 (4 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | 58779NIC8P | 325mg | ||
| HYPROMELLOSE 2208 (4 MPA.S) | SUBLINGUAL | TABLET | 9004653 | 58779NIC8P | 5mg | ||
| HYPROMELLOSE 2208 (4000 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | 39J80LT57T | 78mg | ||
| HYPROMELLOSE 2208 (4000 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | 39J80LT57T | 10mg | ||
| HYPROMELLOSE 2208 (4000 MPA.S) | ORAL | SOLUTION | 9004653 | 39J80LT57T | 88mg | ||
| HYPROMELLOSE 2208 (4000 MPA.S) | ORAL | SUSPENSION | 9004653 | 39J80LT57T | 300mg | ||
| HYPROMELLOSE 2208 (4000 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | 39J80LT57T | 960mg | ||
| HYPROMELLOSE 2208 (4000 MPA.S) | ORAL | TABLET, FILM COATED | 9004653 | 39J80LT57T | 40mg | ||
| HYPROMELLOSE 2208 (4000 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | 39J80LT57T | 96mg | ||
| HYPROMELLOSE 2208 (4000 MPA.S) | TOPICAL | JELLY | 9004653 | 39J80LT57T | 2.3%w/v | ||
| HYPROMELLOSE 2208 (4000 MPA.S) | TOPICAL | LOTION | 9004653 | 39J80LT57T | 0.1%w/w | ||
| HYPROMELLOSE 2208 (4000 MPA.S) | URETHRAL | JELLY | 9004653 | 39J80LT57T | 2.3%w/v | ||
| HYPROMELLOSE 2208 (4000 MPA.S) | VAGINAL | CREAM | 9004653 | 39J80LT57T | 12mg | ||
| HYPROMELLOSE 2906 (4 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | 6531BH494O | 660mg | ||
| HYPROMELLOSE 2906 (4 MPA.S) | ORAL | POWDER | 9004653 | 6531BH494O | 91mg | ||
| HYPROMELLOSE 2906 (4 MPA.S) | RESPIRATORY (INHALATION) | POWDER | 9004653 | 6531BH494O | 45.67mg | ||
| HYPROMELLOSE 2906 (4000 MPA.S) | OPHTHALMIC | SOLUTION | 9004653 | 5EYA69XGAT | 0.5%w/v | ||
| HYPROMELLOSE 2906 (4000 MPA.S) | ORAL | CAPSULE | 9004653 | 5EYA69XGAT | 282mg | ||
| HYPROMELLOSE 2906 (4000 MPA.S) | ORAL | GRANULE, DELAYED RELEASE | 9004653 | 5EYA69XGAT | 33.2mg | ||
| HYPROMELLOSE 2906 (4000 MPA.S) | ORAL | SUSPENSION | 9004653 | 5EYA69XGAT | 184mg | ||
| HYPROMELLOSE 2906 (4000 MPA.S) | ORAL | TABLET | 9004653 | 5EYA69XGAT | 50mg | ||
| HYPROMELLOSE 2906 (4000 MPA.S) | ORAL | TABLET, FILM COATED | 9004653 | 5EYA69XGAT | 20mg | ||
| HYPROMELLOSE 2906 (50 MPA.S) | ORAL | TABLET | 9004653 | 612E703ZUQ | 1.88mg | ||
| HYPROMELLOSE 2906 (50 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | 612E703ZUQ | 88mg | ||
| HYPROMELLOSE 2910 (10000 MPA.S) | ORAL | TABLET | 9004653 | 0HO1H52958 | 188mg | ||
| HYPROMELLOSE 2910 (10000 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | 0HO1H52958 | 524mg | ||
| HYPROMELLOSE 2910 (10000 MPA.S) | VAGINAL | GEL | 9004653 | 0HO1H52958 | 3.5%w/w | ||
| HYPROMELLOSE 2910 (15 MPA.S) | ORAL | CAPSULE | 9004653 | 36SFW2JZ0W | 70mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | 36SFW2JZ0W | 129mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | 36SFW2JZ0W | 71mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | ORAL | FILM, SOLUBLE | 9004653 | 36SFW2JZ0W | 47mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | ORAL | SUSPENSION | 9004653 | 36SFW2JZ0W | 400mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | ORAL | TABLET | 9004653 | 36SFW2JZ0W | 360mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004653 | 36SFW2JZ0W | 120mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | 36SFW2JZ0W | 748mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | ORAL | TABLET, FILM COATED | 9004653 | 36SFW2JZ0W | 48mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | 36SFW2JZ0W | 15mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 9004653 | 36SFW2JZ0W | 54mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | SUBLINGUAL | FILM | 9004653 | 36SFW2JZ0W | 7mg | ||
| HYPROMELLOSE 2910 (15 MPA.S) | VAGINAL | INSERT | 9004653 | 36SFW2JZ0W | 105mg | ||
| HYPROMELLOSE 2910 (15000 MPA.S) | BUCCAL | TABLET | 9004653 | 288VBX44JC | 48mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | OPHTHALMIC | SOLUTION/ DROPS | 9004653 | 0VUT3PMY82 | 0.5%w/v | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | CAPSULE | 9004653 | 0VUT3PMY82 | 400mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | 0VUT3PMY82 | 721mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | 0VUT3PMY82 | 105mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | GRANULE | 9004653 | 0VUT3PMY82 | 295mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | GRANULE, FOR SUSPENSION | 9004653 | 0VUT3PMY82 | 1mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | SUSPENSION | 9004653 | 0VUT3PMY82 | 156mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET | 9004653 | 0VUT3PMY82 | 379mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, COATED | 9004653 | 0VUT3PMY82 | 7.5mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004653 | 0VUT3PMY82 | 140mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | 0VUT3PMY82 | 231mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, FILM COATED | 9004653 | 0VUT3PMY82 | 78mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | 0VUT3PMY82 | 8mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, FOR SUSPENSION | 9004653 | 0VUT3PMY82 | 60mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, ORALLY DISINTEGRATING | 9004653 | 0VUT3PMY82 | 52mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 9004653 | 0VUT3PMY82 | 36mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | NASAL | SPRAY | 9004653 | RN3152OP35 | 1mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | NASAL | SPRAY, METERED | 9004653 | RN3152OP35 | 1mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | OPHTHALMIC | GEL | 9004653 | RN3152OP35 | 197mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | OPHTHALMIC | SOLUTION | 9004653 | RN3152OP35 | 2mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | OPHTHALMIC | SOLUTION/ DROPS | 9004653 | RN3152OP35 | 3mg | Y | |
| HYPROMELLOSE 2910 (4000 MPA.S) | OPHTHALMIC | SUSPENSION | 9004653 | RN3152OP35 | 0.5%w/v | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | OPHTHALMIC | SUSPENSION/ DROPS | 9004653 | RN3152OP35 | 0.6%w/v | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | RN3152OP35 | 190mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | SOLUTION | 9004653 | RN3152OP35 | 360mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | SUSPENSION | 9004653 | RN3152OP35 | 360mg | Y | |
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | SUSPENSION/ DROPS | 9004653 | RN3152OP35 | 10mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | SYRUP | 9004653 | RN3152OP35 | 360mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | TABLET | 9004653 | RN3152OP35 | 54mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | TABLET, CHEWABLE | 9004653 | RN3152OP35 | 264mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | TABLET, COATED | 9004653 | RN3152OP35 | 245mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004653 | RN3152OP35 | 127.29mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | RN3152OP35 | 290mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | RN3152OP35 | 107mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | ORAL | TABLET, FOR SUSPENSION | 9004653 | RN3152OP35 | 90mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | TOPICAL | JELLY | 9004653 | RN3152OP35 | 1368mg | ||
| HYPROMELLOSE 2910 (4000 MPA.S) | TOPICAL | SHAMPOO | 9004653 | RN3152OP35 | 1.2%w/w | ||
| HYPROMELLOSE 2910 (5 MPA.S) | BUCCAL | GUM, CHEWING | 9004653 | R75537T0T4 | 336mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | BUCCAL | TABLET | 9004653 | R75537T0T4 | 5mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | NASAL | POWDER | 9004653 | R75537T0T4 | NA | ||
| HYPROMELLOSE 2910 (5 MPA.S) | NASAL | SPRAY | 9004653 | R75537T0T4 | 1mg/1ml | ||
| HYPROMELLOSE 2910 (5 MPA.S) | NASAL | SPRAY, METERED | 9004653 | R75537T0T4 | 1mg/1ml | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | CAPSULE | 9004653 | R75537T0T4 | 930mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | R75537T0T4 | 563mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | R75537T0T4 | 964mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | CAPSULE, LIQUID FILLED | 9004653 | R75537T0T4 | 1447mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | GRANULE, FOR SUSPENSION | 9004653 | R75537T0T4 | 48mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | POWDER, FOR SUSPENSION | 9004653 | R75537T0T4 | 2940mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | SUSPENSION | 9004653 | R75537T0T4 | 975mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | SUSPENSION, EXTENDED RELEASE | 9004653 | R75537T0T4 | 80mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | SYRUP | 9004653 | R75537T0T4 | 200mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | TABLET | 9004653 | R75537T0T4 | 1200mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | TABLET, CHEWABLE | 9004653 | R75537T0T4 | 120mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | TABLET, COATED | 9004653 | R75537T0T4 | 24mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004653 | R75537T0T4 | 103mg | Y | |
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | R75537T0T4 | 434mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | TABLET, FILM COATED | 9004653 | R75537T0T4 | 264mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | R75537T0T4 | 107mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | TABLET, FOR SUSPENSION | 9004653 | R75537T0T4 | 76mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 9004653 | R75537T0T4 | 68mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | ORAL | TABLET, ORALLY DISINTEGRATING | 9004653 | R75537T0T4 | 25mg | ||
| HYPROMELLOSE 2910 (5 MPA.S) | SUBLINGUAL | FILM | 9004653 | R75537T0T4 | 4.68mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | CAPSULE | 9004653 | 0WZ8WG20P6 | 600mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 9004653 | 0WZ8WG20P6 | 156mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE PELLETS | 9004653 | 0WZ8WG20P6 | 261mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 9004653 | 0WZ8WG20P6 | 232mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | CAPSULE, LIQUID FILLED | 9004653 | 0WZ8WG20P6 | 31mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | FILM, SOLUBLE | 9004653 | 0WZ8WG20P6 | 33.5mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | GRANULE | 9004653 | 0WZ8WG20P6 | 5455mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | GRANULE, FOR SUSPENSION | 9004653 | 0WZ8WG20P6 | 42mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | POWDER, FOR SUSPENSION | 9004653 | 0WZ8WG20P6 | 504mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | TABLET | 9004653 | 0WZ8WG20P6 | 880mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | TABLET, CHEWABLE | 9004653 | 0WZ8WG20P6 | 17mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | TABLET, COATED | 9004653 | 0WZ8WG20P6 | 12mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 9004653 | 0WZ8WG20P6 | 77mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 9004653 | 0WZ8WG20P6 | 85mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | TABLET, FILM COATED | 9004653 | 0WZ8WG20P6 | 60mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004653 | 0WZ8WG20P6 | 8mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | TABLET, ORALLY DISINTEGRATING | 9004653 | 0WZ8WG20P6 | 39mg | ||
| HYPROMELLOSE 2910 (6 MPA.S) | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 9004653 | 0WZ8WG20P6 | 174mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MPA.S) | ORAL | CAPSULE, EXTENDED RELEASE | 71138971 | 6N003M473W | 57mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MPA.S) | ORAL | GRANULE | 71138971 | 6N003M473W | 92mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 12070923 (3 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 71138971 | 36BGF0E889 | 104mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 12070923 (3 MPA.S) | ORAL | TABLET, DELAYED RELEASE | 71138971 | 36BGF0E889 | 2720mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S) | ORAL | CAPSULE, DELAYED RELEASE | 71138971 | 24P2YXD2PW | 99mg | ||
| HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S) | ORAL | TABLET, EXTENDED RELEASE | 71138971 | 24P2YXD2PW | 26mg | ||
| HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED | ORAL | CAPSULE | 71138971 | A7ZHS2RJ34 | 89mg | ||
| HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED | ORAL | CAPSULE, EXTENDED RELEASE | 71138971 | A7ZHS2RJ34 | 67mg | ||
| HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED | ORAL | TABLET | 71138971 | A7ZHS2RJ34 | 4480mg | ||
| HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED | ORAL | TABLET, DELAYED RELEASE | 71138971 | A7ZHS2RJ34 | 1680mg | ||
| HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED | ORAL | TABLET, EXTENDED RELEASE | 71138971 | A7ZHS2RJ34 | 29mg | ||
| HYPROMELLOSE PHTHALATE | ORAL | CAPSULE | 9050311 | NA | 15mg | ||
| HYPROMELLOSE PHTHALATE | ORAL | CAPSULE, COATED PELLETS | 9050311 | NA | 13.26mg | ||
| HYPROMELLOSE PHTHALATE | ORAL | CAPSULE, DELAYED RELEASE | 9050311 | NA | 279mg | ||
| HYPROMELLOSE PHTHALATE | ORAL | CAPSULE, EXTENDED RELEASE | 9050311 | NA | 13mg | ||
| HYPROMELLOSE PHTHALATE | ORAL | TABLET | 9050311 | NA | 104.4mg | ||
| HYPROMELLOSE PHTHALATE | ORAL | TABLET, DELAYED RELEASE | 9050311 | NA | 392mg | ||
| HYPROMELLOSE PHTHALATE | ORAL | TABLET, EXTENDED RELEASE | 9050311 | NA | 77mg | ||
| HYPROMELLOSE PHTHALATE | ORAL | TABLET, ORALLY DISINTEGRATING | 9050311 | NA | 47mg | ||
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | ORAL | CAPSULE | 9050311 | 87Y6436BKR | 585mg | ||
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | ORAL | CAPSULE, DELAYED RELEASE | 9050311 | 87Y6436BKR | 95mg | ||
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | ORAL | CAPSULE, EXTENDED RELEASE | 9050311 | 87Y6436BKR | 103mg | ||
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | ORAL | TABLET | 9050311 | 87Y6436BKR | 1495mg | ||
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | ORAL | TABLET, DELAYED RELEASE | 9050311 | 87Y6436BKR | 411mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST) | ORAL | CAPSULE, DELAYED RELEASE | 9050311 | 8LDD2V82F5 | 129mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST) | ORAL | TABLET, DELAYED RELEASE | 9050311 | 8LDD2V82F5 | 49mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | CAPSULE | 9050311 | G4U024CQK6 | 63.92mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | CAPSULE, DELAYED RELEASE | 9050311 | G4U024CQK6 | 586mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | CAPSULE, EXTENDED RELEASE | 9050311 | G4U024CQK6 | 44mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | GRANULE, FOR SUSPENSION | 9050311 | G4U024CQK6 | 1217mg | Y | |
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | TABLET | 9050311 | G4U024CQK6 | 152mg | ||
| HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST) | ORAL | TABLET, EXTENDED RELEASE | 9050311 | G4U024CQK6 | 13mg | ||
| HYSTRENE | ORAL | CAPSULE | 8039325 | NA | NA | ||
| HYSTRENE | ORAL | TABLET | 8039325 | NA | 7mg |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: January 5, 2024
Database Last Updated: January 26, 2024